Back to search

Article

TNF-α suppresses drug resistance via NF-κB/PXR pathway in non-small cell lung cancer

2021-01-20

Abstract excerpt

<h4>Background: </h4> Reduced sensitivity to chemotherapeutic agents caused by multidrug resistance is the main obstacle in the treatment of non-small cell lung cancer (NSCLC). Activated NF-κB/PXR pathway stimulated by procytokine TNF-α is implicated in the formation of multidrug resistance phenotype. However, the underlying mechanisms are obscure, and results concluded in various tumors are conflicted. Herein, we...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
52df61cd-ec26-5fc8-b97f-6003989e625e
DOI
10.21203/rs.3.rs-148624/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
TNF-α suppresses drug resistance via NF-κB/PXR pathway in non-small cell lung cancerDOI 10.21203/rs.3.rs-148624/v1
Select a neighboring publication to make it the new centre.